Fluorine-18 Labeled MIBG Analogues for Theranostic Applications

David Raffel, PhD

Year: 2019
Institution: The Regents of the University of Michigan
Country: United States
State: MI
Award Type: Investigator
NET Type: Multiple
Science Type: Clinical

The primary goals are to evaluate possible liver, bone marrow and kidney toxicity after hepatic arterial injection and evaluate imaging tumor response to 90Y-DOTA-TOC hepatic arterial injection three months after treatment. Dr. Hope will evaluate possible 90Y-DOTA-TOC hepatic, marrow and renal toxicity and imaging of tumor response to hepatic arterial injection, three months post-therapy.

Read more about this study